Skip to main content
Philip Katz, MD, Gastroenterology, New York, NY

PhilipKatzMD

Gastroenterology New York, NY

Advanced Endoscopic Interventional, Esophagus Disease

Clinical Professor of Medicine, Thomas Jefferson University

Overview of Dr. Katz

Dr. Philip Katz is a gastroenterologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. He received his medical degree from Wake Forest School of Medicine of Wake Forest Baptist Medical Center and has been in practice 39 years. Dr. Katz accepts several types of health insurance, listed below. He is one of 303 doctors at New York-Presbyterian Hospital and one of 303 doctors at New York-Presbyterian Hospital who specialize in Gastroenterology. He has more than 100 publications and over 500 citings.

Education & Training

  • Wake Forest University Baptist Medical Center
    Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1979 - 1982
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1978
  • Wake Forest University Baptist Medical Center
    Wake Forest University Baptist Medical CenterFellowship, Gastroenterology

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - Present
  • NY State Medical License
    NY State Medical License 2017 - 2026
  • PA State Medical License
    PA State Medical License 1996 - 2018
  • NC State Medical License
    NC State Medical License 1978 - 2002
  • MD State Medical License
    MD State Medical License 1986 - 1996
  • NJ State Medical License
    NJ State Medical License 1962 - 1993
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Lectures

  • Proton Pump Inhibitors: How to Help Get Your Patients Off of Them 
    AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018
  • GERD – Weighing the Risks and Benefits 
    AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/9/2018
  • PPI Risks: Separating Fact From Fiction 
    AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/7/2018

Press Mentions

  • Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3 PHALCON-NERD-301 Trial Evaluating Daily Dosing of Vonoprazan for Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)
    Phathom Pharmaceuticals Announces Positive Topline Results from Phase 3 PHALCON-NERD-301 Trial Evaluating Daily Dosing of Vonoprazan for Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)January 8th, 2023
  • Dupilumab Effective for Eosinophilic Esophagitis up to 52 Weeks
    Dupilumab Effective for Eosinophilic Esophagitis up to 52 WeeksDecember 28th, 2022
  • Higher BMI May Dampen Steroid Response in Eosinophilic Esophagitis
    Higher BMI May Dampen Steroid Response in Eosinophilic EsophagitisDecember 5th, 2022
  • Join now to see all

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AmeriHealth Direct POS
    Amerihealth HMO
    AmeriHealth PPO
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Carelink Health Plans PPO
    First Health PPO
    Great West PPO
    HealthAmerica HealthAssurance PPO
    Horizon BCBS PPO
    Humana ChoiceCare Network PPO
    IBC Keystone HMO / POS
    IBC Personal Choice PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment